{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T09:09:58Z","timestamp":1790500198568,"version":"4.1.0"},"reference-count":53,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2018,10,31]],"date-time":"2018-10-31T00:00:00Z","timestamp":1540944000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Funda\u00e7\u00e3o da Ci\u00eancia e Tecnologia","award":["PTDC\/BBB-BMD\/6301\/2014 (2016)"],"award-info":[{"award-number":["PTDC\/BBB-BMD\/6301\/2014 (2016)"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>In order to delineate a better approach to functional studies, we have selected 23 missense mutations distributed in different domains of two lysosomal enzymes, to be studied by in silico analysis. In silico analysis of mutations relies on computational modeling to predict their effects. Various computational platforms are currently available to check the probable causality of mutations encountered in patients at the protein and at the RNA levels. In this work we used four different platforms freely available online (Protein Variation Effect Analyzer- PROVEAN, PolyPhen-2, Swiss-model Expert Protein Analysis System\u2014ExPASy, and SNAP2) to check amino acid substitutions and their effect at the protein level. The existence of functional studies, regarding the amino acid substitutions, led to the selection of the distinct protein mutants. Functional data were used to compare the results obtained with different bioinformatics tools. With the advent of next-generation sequencing, it is not feasible to carry out functional tests in all the variants detected. In silico analysis seems to be useful for the delineation of which mutants are worth studying through functional studies. Therefore, prediction of the mutation impact at the protein level, applying computational analysis, confers the means to rapidly provide a prognosis value to genotyping results, making it potentially valuable for patient care as well as research purposes. The present work points to the need to carry out functional studies in mutations that might look neutral. Moreover, it should be noted that single nucleotide polymorphisms (SNPs), occurring in coding and non-coding regions, may lead to RNA alterations and should be systematically verified. Functional studies can gain from a preliminary multi-step approach, such as the one proposed here.<\/jats:p>","DOI":"10.3390\/ijms19113409","type":"journal-article","created":{"date-parts":[[2018,10,31]],"date-time":"2018-10-31T11:55:41Z","timestamp":1540986941000},"page":"3409","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["In Silico Analysis of Missense Mutations as a First Step in Functional Studies: Examples from Two Sphingolipidoses"],"prefix":"10.3390","volume":"19","author":[{"given":"Ana Joana","family":"Duarte","sequence":"first","affiliation":[{"name":"Instituto Nacional de Sa\u00fade Dr Ricardo Jorge (INSA, IP), Departamento de Gen\u00e9tica Humana, Unidade de Investiga\u00e7\u00e3o e Desenvolvimento, Rua Alexandre Herculano 321, 4000-055 Porto, Portugal"},{"name":"ICBAS, University of Porto, 4099-002 Porto, Portugal"},{"name":"CECA, ICETA, University of Porto, 4099-002 Porto, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diogo","family":"Ribeiro","sequence":"additional","affiliation":[{"name":"Instituto Nacional de Sa\u00fade Dr Ricardo Jorge (INSA, IP), Departamento de Gen\u00e9tica Humana, Unidade de Investiga\u00e7\u00e3o e Desenvolvimento, Rua Alexandre Herculano 321, 4000-055 Porto, Portugal"},{"name":"CECA, ICETA, University of Porto, 4099-002 Porto, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5369-5422","authenticated-orcid":false,"given":"Luciana","family":"Moreira","sequence":"additional","affiliation":[{"name":"Instituto Nacional de Sa\u00fade Dr Ricardo Jorge (INSA, IP), Departamento de Gen\u00e9tica Humana, Unidade de Investiga\u00e7\u00e3o e Desenvolvimento, Rua Alexandre Herculano 321, 4000-055 Porto, Portugal"},{"name":"CECA, ICETA, University of Porto, 4099-002 Porto, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Amaral","sequence":"additional","affiliation":[{"name":"Instituto Nacional de Sa\u00fade Dr Ricardo Jorge (INSA, IP), Departamento de Gen\u00e9tica Humana, Unidade de Investiga\u00e7\u00e3o e Desenvolvimento, Rua Alexandre Herculano 321, 4000-055 Porto, Portugal"},{"name":"CECA, ICETA, University of Porto, 4099-002 Porto, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2018,10,31]]},"reference":[{"key":"ref_1","unstructured":"Scriver, C.R., Beaudet, A.L., Sly, W.S., and Valle, D. (2001). Gaucher disease. The Metabolic and Molecular Bases of Inherited Disease, McGraw-Hill. [8th ed.]."},{"key":"ref_2","unstructured":"Scriver, C.R., Beaudet, A.L., Sly, W.S., and Valle, D. (2001). \u03b1-Galactosidase A deficiency: Fabry disease. The Metabolic and Molecular Bases of Inherited Disease, McGraw-Hill. [8th ed.]."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"4816","DOI":"10.1021\/bi9002265","article-title":"Effects of pH and iminosugar pharmacological chaperones on lysosomal glycosidase structure and stability","volume":"48","author":"Lieberman","year":"2009","journal-title":"Biochemistry"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1038\/sj.embor.embor873","article-title":"X-ray structure of human acid-beta-glucosidase, the defective enzyme in Gaucher disease","volume":"4","author":"Dvir","year":"2003","journal-title":"EMBO Rep."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.jmb.2004.01.035","article-title":"The molecular defect leading to Fabry disease: Structure of human alpha-galactosidase","volume":"337","author":"Garman","year":"2004","journal-title":"J. Mol. Biol."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Vogel, H.G., Maas, J., Hock, F.J., and Mayer, D. (2013). In Silico Methods. Drug Discovery and Evaluation: Safety and Pharmacokinetic Assays, Springer.","DOI":"10.1007\/978-3-642-25240-2"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1373\/clinchem.2004.036053","article-title":"In silico prediction of the deleterious effect of a mutation: Proceed with caution in clinical genetics","volume":"50","author":"Tchernitchko","year":"2004","journal-title":"Clin. Chem."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1002\/bmb.20966","article-title":"Using the PyMOL application to reinforce visual understanding of protein structure","volume":"44","author":"Rigsby","year":"2016","journal-title":"Biochem. Mol. Biol. Educ."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"3937","DOI":"10.1016\/j.jmb.2013.07.028","article-title":"News from the protein mutability landscape","volume":"425","author":"Hecht","year":"2013","journal-title":"J. Mol. Biol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1186\/1471-2164-16-S8-S1","article-title":"Better prediction of functional effects for sequence variants","volume":"16","author":"Hecht","year":"2015","journal-title":"BMC Genom."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"3823","DOI":"10.1093\/nar\/gkm238","article-title":"SNAP: Predict effect of non-synonymous polymorphisms on function","volume":"35","author":"Bromberg","year":"2007","journal-title":"Nucleic Acids Res."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/sj.ejhg.5200422","article-title":"Gaucher disease: Expression and characterization of mild and severe acid beta-glucosidase mutations in Portuguese type 1 patients","volume":"8","author":"Amaral","year":"2000","journal-title":"Eur. J. Hum. Genet."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1002\/humu.20043","article-title":"Functional analysis of 13 GBA mutant alleles identified in Gaucher disease patients: Pathogenic changes and \u201cmodifier\u201d polymorphisms","volume":"23","author":"Montfort","year":"2004","journal-title":"Hum. Mutat."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.bcmd.2005.03.006","article-title":"Use of fluorescent substrates for characterization of Gaucher disease mutations","volume":"35","author":"Ron","year":"2005","journal-title":"Blood Cells Mol. Dis."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.bcmd.2005.04.007","article-title":"Perinatal lethal phenotype with generalized ichthyosis in a type 2 Gaucher disease patient with the [L444P;E326K]\/P182L genotype: Effect of the E326K change in neonatal and classic forms of the disease","volume":"35","author":"Chabas","year":"2005","journal-title":"Blood Cells Mol. Dis."},{"key":"ref_16","first-page":"646","article-title":"Gaucher disease: Heterologous expression of two alleles associated with neuronopathic phenotypes","volume":"49","author":"Grace","year":"1991","journal-title":"Am. J. Hum. Genet."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"4242","DOI":"10.1074\/jbc.M511110200","article-title":"Analyses of variant acid beta-glucosidases: Effects of Gaucher disease mutations","volume":"281","author":"Liou","year":"2006","journal-title":"J. Biol. Chem."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Lukas, J., Giese, A.K., Markoff, A., Grittner, U., Kolodny, E., Mascher, H., Lackner, K.J., Meyer, W., Wree, P., and Saviouk, V. (2013). Functional characterisation of alpha-galactosidase a mutations as a basis for a new classification system in fabry disease. PLoS Genet., 9.","DOI":"10.1371\/journal.pgen.1003632"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3858\/emm.2009.41.1.001","article-title":"Effects of a chemical chaperone on genetic mutations in alpha-galactosidase A in Korean patients with Fabry disease","volume":"41","author":"Park","year":"2009","journal-title":"Exp. Mol. Med."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1086\/504601","article-title":"High incidence of later-onset fabry disease revealed by newborn screening","volume":"79","author":"Spada","year":"2006","journal-title":"Am. J. Hum. Genet."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.ymgme.2014.11.004","article-title":"The alpha-galactosidase A p.Arg118Cys variant does not cause a Fabry disease phenotype: Data from individual patients and family studies","volume":"114","author":"Ferreira","year":"2015","journal-title":"Mol. Genet. Metab."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S1096-7192(03)00136-7","article-title":"Fabry disease: D313Y is an alpha-galactosidase A sequence variant that causes pseudodeficient activity in plasma","volume":"80","author":"Froissart","year":"2003","journal-title":"Mol. Genet. Metab."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1002\/humu.10275","article-title":"Fabry disease: Characterization of alpha-galactosidase A double mutations and the D313Y plasma enzyme pseudodeficiency allele","volume":"22","author":"Yasuda","year":"2003","journal-title":"Hum. Mutat."},{"key":"ref_24","first-page":"51","article-title":"Multiple mutations are responsible for the high frequency of metachromatic leukodystrophy in a small geographic area","volume":"56","author":"Heinisch","year":"1995","journal-title":"Am. J. Hum. Genet."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1002\/ajmg.a.30118","article-title":"Novel mutations associated with metachromatic leukodystrophy: Phenotype and expression studies in nine Czech and Slovak patients","volume":"129A","author":"Gieselmann","year":"2004","journal-title":"Am. J. Med. Genet. A"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/(SICI)1098-1004(1996)7:4<311::AID-HUMU4>3.0.CO;2-B","article-title":"Characterization of two arylsulfatase A missense mutations D335V and T274M causing late infantile metachromatic leukodystrophy","volume":"7","author":"Hess","year":"1996","journal-title":"Hum. Mutat."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1002\/(SICI)1098-1004(1999)13:4<337::AID-HUMU14>3.0.CO;2-9","article-title":"Metachromatic leucodystrophy in Portugal-finding of four new molecular lesions: C300F, P425T, g.1190-1191insC, and g.2408delC. Mutations in brief no. 232. Online","volume":"13","author":"Amaral","year":"1999","journal-title":"Hum. Mutat."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"3654","DOI":"10.1021\/bi9714924","article-title":"Crystal structure of human arylsulfatase A: The aldehyde function and the metal ion at the active site suggest a novel mechanism for sulfate ester hydrolysis","volume":"37","author":"Lukatela","year":"1998","journal-title":"Biochemistry"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/BF00201666","article-title":"Single exon mutation in arylsulfatase A gene has two effects: Loss of enzyme activity and aberrant splicing","volume":"93","author":"Hasegawa","year":"1994","journal-title":"Hum. Genet."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1007\/s004390050532","article-title":"Adult onset globoid cell leukodystrophy (Krabbe disease): Analysis of galactosylceramidase cDNA from four Japanese patients","volume":"100","author":"Furuya","year":"1997","journal-title":"Hum. Genet."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1002\/(SICI)1098-1004(1999)14:3<256::AID-HUMU9>3.0.CO;2-6","article-title":"Molecular basis of late-life globoid cell leukodystrophy","volume":"14","author":"Sartorato","year":"1999","journal-title":"Hum. Mutat."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1023\/A:1005449919660","article-title":"Molecular heterogeneity of Krabbe disease","volume":"22","author":"Fu","year":"1999","journal-title":"J. Inherit. Metab. Dis."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Matos, L., Duarte, A.J., Ribeiro, D., Chaves, J., Amaral, O., and Alves, S. (2018). Correction of a Splicing Mutation Affecting an Unverricht-Lundborg Disease Patient by Antisense Therapy. Genes, 9.","DOI":"10.3390\/genes9090455"},{"key":"ref_34","first-page":"342","article-title":"Identification of mutations in cystatin B, the gene responsible for the Unverricht-Lundborg type of progressive myoclonus epilepsy (EPM1)","volume":"60","author":"Lalioti","year":"1997","journal-title":"Am. J. Hum. Genet."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/0014-5793(95)00175-9","article-title":"Hairpin loop mutations of chicken cystatin have different effects on the inhibition of cathepsin B, cathepsin L and papain","volume":"361","author":"Auerswald","year":"1995","journal-title":"FEBS Lett."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/sj.ejhg.5201723","article-title":"Cystatin B: Mutation detection, alternative splicing and expression in progressive myclonus epilepsy of Unverricht-Lundborg type (EPM1) patients","volume":"15","author":"Joensuu","year":"2007","journal-title":"Eur. J. Hum. Genet."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1038\/sj.ejhg.5201300","article-title":"Loss of lysosomal association of cystatin B proteins representing progressive myoclonus epilepsy, EPM1, mutations","volume":"13","author":"Alakurtti","year":"2005","journal-title":"Eur. J. Hum. Genet."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.ymgme.2011.07.002","article-title":"The enigma of the E326K mutation in acid \u03b2-glucocerebrosidase","volume":"104","author":"Horowitz","year":"2011","journal-title":"Mol. Genet. Metab."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.eplepsyres.2011.11.004","article-title":"Unverricht-Lundborg disease: Homozygosity for a new splicing mutation in the cystatin B gene","volume":"99","author":"Pinto","year":"2012","journal-title":"Epilepsy Res."},{"key":"ref_40","first-page":"68","article-title":"Characterization of a rare Unverricht-Lundborg disease mutation","volume":"4","author":"Duarte","year":"2015","journal-title":"Mol. Genet. Metab. Rep."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"411","DOI":"10.3233\/JPD-171092","article-title":"Glucocerebrosidase Mutations in Parkinson Disease","volume":"7","author":"Balestrino","year":"2017","journal-title":"J. Parkinsons Dis."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/jnc.13385","article-title":"The relationship between glucocerebrosidase mutations and Parkinson disease","volume":"139","author":"Schapira","year":"2016","journal-title":"J. Neurochem."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.neulet.2017.08.040","article-title":"The GBA variant E326K is associated with Parkinson\u2019s disease and explains a genome-wide association signal","volume":"658","author":"Forsgren","year":"2017","journal-title":"Neurosci. Lett."},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Thirumal Kumar, D., Eldous, H.G., Mahgoub, Z.A., George Priya Doss, C., and Zayed, H. (2018). Computational modelling approaches as a potential platform to understand the molecular genetics association between Parkinson\u2019s and Gaucher diseases. Metab. Brain Dis.","DOI":"10.1007\/s11011-018-0286-3"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"e67","DOI":"10.1093\/nar\/gkp215","article-title":"Human Splicing Finder: An online bioinformatics tool to predict splicing signals","volume":"37","author":"Desmet","year":"2009","journal-title":"Nucleic Acids Res."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1093\/nar\/29.5.1185","article-title":"GeneSplicer: A new computational method for splice site prediction","volume":"29","author":"Pertea","year":"2001","journal-title":"Nucleic Acids Res."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"3439","DOI":"10.1093\/nar\/24.17.3439","article-title":"Splice site prediction in Arabidopsis thaliana pre-mRNA by combining local and global sequence information","volume":"24","author":"Hebsgaard","year":"1996","journal-title":"Nucleic Acids Res."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1089\/cmb.1997.4.311","article-title":"Improved splice site detection in Genie","volume":"4","author":"Reese","year":"1997","journal-title":"J. Comput. Biol."},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Choi, Y., Sims, G.E., Murphy, S., Miller, J.R., and Chan, A.P. (2012). Predicting the functional effect of amino acid substitutions and indels. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0046688"},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Choi, Y. (2012, January 7\u201310). A fast computation of pairwise sequence alignment scores between a protein and a set of single-locus variants of another protein. Proceedings of the ACM Conference on Bioinformatics, Computational Biology and Biomedicine, Orlando, FL, USA.","DOI":"10.1145\/2382936.2382989"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/nmeth0410-248","article-title":"A method and server for predicting damaging missense mutations","volume":"7","author":"Adzhubei","year":"2010","journal-title":"Nat. Methods"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"S162","DOI":"10.1002\/elps.200900140","article-title":"Automated comparative protein structure modeling with SWISS-MODEL and Swiss-PdbViewer: A historical perspective","volume":"30","author":"Guex","year":"2009","journal-title":"Electrophoresis"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"W597","DOI":"10.1093\/nar\/gks400","article-title":"ExPASy: SIB bioinformatics resource portal","volume":"40","author":"Artimo","year":"2012","journal-title":"Nucleic Acids Res."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/19\/11\/3409\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T15:27:06Z","timestamp":1760196426000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/19\/11\/3409"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,31]]},"references-count":53,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2018,11]]}},"alternative-id":["ijms19113409"],"URL":"https:\/\/doi.org\/10.3390\/ijms19113409","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,31]]}}}